A Novel Intermediate Alemtuzumab Schedule Optimizes the Incidences of Mixed Chimerism and Acute GVHD in Patients With HLH and XLP Undergoing Allogeneic HCT

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2012.11.433
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Alemtuzumab Controls Acute GVHD and Mixed Chimerism Risks in Pediatric Patients With HLH Undergoing Stem Cell Transplantation: A Correlative Biology Study From the CTN 1204 Richi Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

T-Rapa6 and T-Rapa12 Cells Differentially Mediate Acute GVHD After Low-Intensity Allogeneic HCT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Successful Allogeneic Hematopoietic Cell Transplantation (HCT) With Low Toxicity and GVHD in a Heterogeneous Cohort of Primary Immunodeficiency (PID) Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Long-Term Stable Mixed Chimerism in Patients Undergoing HSCT for Non-Malignant Disorders

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Upfront Allogeneic HCT vs Remission Induction Chemotherapy Followed by Allogeneic HCT for Acute Myeloid Leukemia With Multilineage Dysplasia: A Propensity Score Matched Analysis

American Journal of Hematology
Hematology
2018English

Mixed T Lymphocyte Chimerism After Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients With Hematological Remission and Full Chimerism at Day 30

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Disease Progression Is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Prevention of Relapse in Pediatric Patients With Acute Leukemias and MDS After Allogeneic SCT by Early Immunotherapy Initiated on the Basis of Increasing Mixed Chimerism: A Single Center Experience of 12 Children

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy